Altre lingue Shanghai Medicilon Inc.

Azioni

688202

CNE100003NQ8

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 12/07/2024			Variaz. 5gg	Var. 1 gen.
28,99 ^CNY	-0,38%		+6,58%	-57,60%

29/04	Shanghai Medicilon Inc. (SHSE:688202) annuncia un riacquisto di azioni per un valore di 20 milioni di CNY.	CI
28/04	Shanghai Medicilon Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023.	13/05
Shanghai Medicilon Inc.'s Equity Buyback announced on November 13, 2023, has closed with 745,166 shares, representing 0.55% for CNY 39.98 million.	12/05
Shanghai Medicilon Inc. announces an Equity Buyback for CNY 20 million worth of its shares.	29/04
Shanghai Medicilon Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04
Shanghai Medicilon Inc. authorizes a Buyback Plan.	26/04
Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023.	02/04
China Healthcare Stocks Rally on Hopes for Government Support	14/03
Medicilon Appoints Dr. Qingcong Lin as President of Medicilon Usa Corp	11/03
Shanghai Medicilon Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Medicilon Appoints Dr. Zhang Haizhou as President of Preclinical R&D Unit	09/01
Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023.	03/01
Shanghai Medicilon Inc.(SHSE:688202) dropped from Shanghai Stock Exchange Health Care Sector Index	08/12
Shanghai Medicilon Inc. announces an Equity Buyback for CNY 40 million worth of its shares.	13/11
Shanghai Medicilon Inc. authorizes a Buyback Plan.	13/11
Shanghai Medicilon Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Shanghai Medicilon Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23
Fosun Health Capital Reaches Cooperation Agreement with Medicilon to Explore Innovative Drug Research and Development Together	31/07/23
Five times in a row, Medicilon was shortlisted in the '2022 China CXO Enterprises Top 20 List'	13/07/23
Medicilon topped the 'Top 10 Most Influential CRO Enterprises' in the 2023 China Biopharmaceutical Industry Value List	13/07/23
Shanghai Medicilon Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Shanghai Medicilon Inc.

Azioni

688202

CNE100003NQ8

Altre lingue

Filtri